Skip to content
AMEAmetek

What Is AME Fair Value?

Ametek (AME) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Ametek (AME) has a composite fair value estimate of $103.70 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $236.25, suggesting the stock is overvalued by 56.1%.

Data as of August 29, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$103.70

vs. current price of $236.25(-56.1%)

Undervalued$103.70Overvalued
$236.25

How Is AME Fair Value Calculated?

Four independent models estimate what AME is worth. Each uses different inputs and assumptions. The composite blends them by weight.

AME Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$131.46

-44.4%

Overvalued

Inputs used

FCF: 1.5BGrowth: 10.2%Discount: 10%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$29.21

-87.6%

Overvalued

Inputs used

Dividend: $1.36/yrReq. Return: 10%Growth: 5.1%

AME Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$95.95

-59.4%

Overvalued

Inputs used

EPS: $8.33Book Value: $49.12

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$84.81

-64.1%

Overvalued

Inputs used

EPS: $8.33Growth: 10.2%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$131.46Overvalued

Current price $236.25 is 44.4% above this estimate

CheapFair ValueExpensive
10.2%
0.0%30.0%
9.7%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$1.64B$1.50B
Year 2$1.81B$1.50B
Year 3$2.00B$1.51B
Year 4$2.20B$1.52B
Year 5$2.42B$1.52B
Year 6$2.67B$1.53B
Year 7$2.94B$1.53B
Year 8$3.24B$1.54B
Year 9$3.57B$1.55B
Year 10$3.93B$1.55B
Terminal Value$55.73B$22.01B

What Are AME's Key Financial Metrics?

Earnings & Growth

Current Price

$236.25

EPS (TTM)

$6.64

Forward P/E

26.2

Profit Margin

20.0%

Cash & Balance Sheet

Free Cash Flow

1.5B

EBITDA

2.5B

Book Value

$49.12

Total Debt

2.3B

What Do Analysts Say About AME?

Low

$217.00

Average

$277.50

High

$316.00

Upside

+17.5%

Current $236.25Avg Target $277.50Buy18 analysts

AME Fair Value FAQ

What is the fair value of AME?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), AME's estimated fair value is $103.70. The stock is currently trading at $236.25, which makes it overvalued by our analysis.

How is AME's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is AME overvalued or undervalued?

Based on our analysis, AME is overvalued. The current price of $236.25 is 56.1% above our estimated fair value of $103.70.

What do Wall Street analysts say about AME?

18 analysts cover Ametek with a consensus rating of "Buy." The average price target is $277.50, ranging from $217.00 to $316.00. This implies 17.5% upside from the current price.